Approval · Notice of Compliance 5519 · 1994
PROKINE: Notice of Compliance 5519
Issued June 23, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5519
- Date
- June 23, 1994
- Company
- Hoechst Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Hematopoietic growth factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROKINE | 02060612 | — |
| PROKINE | 02060620 | — |
Medicinal ingredients
- SARGRAMOSTIM 250 MCG per VIAL
- SARGRAMOSTIM 500 MCG per VIAL